Results from a trial of an intravenous infusion of a potent vasodilatory agent in patients with acute decompensated heart failure fundamentally changes scientific thinking about the disease and treatment strategies, an expert has said. Dr Milton Parker from Baylor University Medical Centre in Dallas, Texas presented the findings from TRUE-AHF at the American Heart Association’s ...
TRUE-AHF results raise questions around ADHF disease process
By Sunalie Silva
17 Nov 2016